Profile of sales and notifications of suspected adverse events related to hydroxychloroquine and chloroquine during the COVID-19 pandemic. RSD [Internet]. 2023 Jan. 30 [cited 2025 Dec. 5];12(2):e15112240021. Available from: https://rsdjournal.org/rsd/article/view/40021